RARE DISEASES A–Z · LETTER A
Aplastic Anemia
Aplastic anemia is a rare condition in which the bone marrow — the factory that makes red cells, white cells, and platelets — largely stops producing them. The marrow is not replaced by cancer; it is left empty, or aplastic. The result is a shortage of all three cell lines at once, called pancytopenia.
By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026
Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.
The guide
The basics
In most cases the body's own immune system attacks the marrow's stem cells; in others the trigger is a medicine, a chemical such as benzene, radiation, or a viral infection, and a minority of cases are inherited marrow-failure conditions that usually show in childhood. With all three cell lines down, symptoms combine: fatigue, pallor, and breathlessness from anaemia; infections that are frequent, severe, or slow to clear from low white cells; and bruising, nosebleeds, bleeding gums, and tiny skin haemorrhages from low platelets. Onset can be gradual over months or, less often, abrupt. Aplastic anemia can occur at any age, with peaks in young adults and in later life.
How it works
A blood count showing all three lines low, with few young red cells (reticulocytes), raises the suspicion. The confirming test is a bone marrow biopsy: in aplastic anemia the marrow is strikingly empty of blood-forming cells and replaced by fat, without cancer or scarring. Doctors grade severity by how low the counts are, because severity drives treatment choice. The work-up also looks for causes and mimics — inherited conditions (chromosome-breakage and telomere tests in younger patients), a related blood clone called PNH, vitamin deficiencies, and leukaemia or marrow scarring, which need different treatment. HLA typing is done early so a transplant donor search can start without delay if needed.
Day to day
For younger patients with a matched sibling donor, a stem cell (bone marrow) transplant offers the best chance of cure. For others, the standard is immunosuppressive therapy — a combination that includes horse anti-thymocyte globulin and ciclosporin — now usually given with a growth-factor-like medicine (a thrombopoietin receptor agonist) that nudges the remaining stem cells to produce more, which has improved response rates. Responses take months, so transfusions of red cells and platelets bridge the gap, with iron-overload monitoring if transfusions are many. Infection precautions matter while white cells are low: prompt treatment of fever is a standing rule. Many people respond well; some need a second course or a later transplant, and long-term follow-up watches for relapse or evolution into other blood conditions.
When to get help
Care sits with haematology, usually at centres experienced in marrow failure. Between appointments, the safety rules are simple and strict: fever while your white count is low is an emergency, unusual bleeding needs same-day advice, and new medicines should be checked against the marrow before starting. Vaccination plans and dental care are coordinated with the team. If you were treated with immunosuppression, keep long-term follow-up even when counts are normal — late relapse and related blood conditions can appear years later, and routine blood counts catch them early. Young patients and families should also ask about inherited-cause testing, because it changes transplant donor choice within the family.
Common questions
Is aplastic anemia a cancer?
No. The marrow is empty rather than taken over by cancer cells. It is usually an immune attack on stem cells. However, it needs specialist care because a small number of cases later evolve into related blood conditions, which is one reason long-term follow-up matters.
What is the difference between aplastic anemia and ordinary anemia?
Ordinary anaemia means only red cells are low, and the marrow is usually working hard to compensate. In aplastic anemia all three cell lines — red cells, white cells, and platelets — are low because the marrow itself has failed, which adds infection and bleeding risk to the anaemia.
Can aplastic anemia come back after treatment?
Yes. After immunosuppression, roughly a third of responders relapse at some point, though estimates vary; many respond again to further treatment. Transplant, when it works, is usually curative. Regular blood counts are how relapse is caught early.
Why was I told to avoid some medicines?
A number of medicines can suppress the bone marrow, and a few are linked to triggering aplastic anemia. While your marrow is recovering, your team will review anything new — including over-the-counter and herbal products — before you take it.
More in Letter A
Related
Sources
- Aplastic Anemia (MedlinePlus)
- Aplastic Anemia — Genetic and Rare Diseases Information Center (NIH GARD)
- Aplastic Anemia (NHLBI)
This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Transfusion thresholds and infection rules are set by your haematology team; follow their instructions over general guidance.